FDA Investigator: Rebecca E. Dombrowski

- Rebecca E. Dombrowski first started conducting FDA inspections in 2003, with the last inspection in 2019. Over that time, Rebecca E. Dombrowski has conducted 131 inspections at 88 companies across 91 sites.

Documents

FDA 483 Portage Pharmacy, Portage | March 2013

Available - $199
Rebecca E. Dombrowski
Animal Drugs & Feed Form 483

FDA 483 Pfizer, Rochester | June 2012

Available - $199
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Deva Holding AS - Cerkezkoy Subesi, Cerkezkoy | 2019

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Cipla Limited, Vasco Da Gama | 2018

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Catalent Pharma Solutions Limited, Swindon | 2018

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Mylan Pharmaceuticals Inc, Morgantown | 2017

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Par Sterile Products LLC, Rochester | 2016

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Cenexi, Fontenay Sous Bois | 2016

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 F. Hoffmann-LaRoche Ltd., Basel | 2014

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 American Pharmaceutical Ingredients LLC, Waterford | 2014

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Division of Nuclear Medicine PET Radiopharmaceutical Prd., Ann Arbor | 2014

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Spectron MRC, LLC, South Bend | 2013

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Children's Hospital of Michigan, PET Site, Detroit | 2013

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Bristol-Myers Squibb Company, Inc., Mount Vernon | 2013

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Praxair Inc., River Rouge | 2013

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Grand River Aseptic Manufacturing, Inc., Grand Rapids | 2013

Out-of-stock
Rebecca E. Dombrowski
Biologic Form 483

FDA 483 AMRI Burlington, Inc., Burlington | 2013

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Envigo Analytics Limited, Huntingdon | 2013

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Huntingdon Life Sciences Ltd.dba NDA Analytics Ltd., Huntingdon | 2013

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Pharmazeutische Fabrik Dr. Reckeweg & Co. GmbH, Bensheim | 2013

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Purac BioQuimica, S.A., Montmelo | 2013

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Purac BioQuimica, S.A., Montmelo (Barcelona) | 2013

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Baxter Pharmaceutical Solutions, LLC, Bloomington | 2013

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Petnet Solutions, Inc., Royal Oak, Royal Oak | 2013

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Caraco Pharmaceutical Laboratories, LTD., Detroit | 2013

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 JHP Pharmaceuticals, LLC, Rochester | 2012

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Pfizer Inc, Rochester | 2012

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Merck Serono S.p.A., Modugno | 2012

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Pharmacia & Upjohn LLC, Kalamazoo | 2012

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

FDA 483 Caraco Pharmaceutical Laboratories, LTD., Detroit | 2012

Out-of-stock
Rebecca E. Dombrowski
Human Drug Form 483

Co-Investigators (73)